Cytokinetics Dirección
Dirección controles de criterios 3/4
El CEO de Cytokinetics es Robert Blum , nombrado en Feb 2006, tiene una permanencia de 18.75 años. compensación anual total es $8.75M, compuesta por 9% salario y 91% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.23% de las acciones de la empresa, por valor de $13.44M. La antigüedad media del equipo directivo y de la junta directiva es de 3.6 años y 11.8 años, respectivamente.
Información clave
Robert Blum
Chief Executive Officer (CEO)
US$8.8m
Compensación total
| Porcentaje del salario del CEO | 9.0% |
| Permanencia del CEO | 18.8yrs |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | 3.6yrs |
| Promedio de permanencia en la Junta Directiva | 11.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Cytokinetics: On The Cusp Of Commercialization
Nov 14Cytokinetics: Aficamten Rolling NDA Submission Leads To Expansion Opportunities
Aug 13Is Cytokinetics (NASDAQ:CYTK) Weighed On By Its Debt Load?
Aug 11
Cytokinetics' Aficamten: Heartfelt Potential Amid Market Woes
Jul 24Cytokinetics Decides To Go It Alone
May 24Here's Why We Think Cytokinetics, Incorporated's (NASDAQ:CYTK) CEO Compensation Looks Fair for the time being
May 09Cytokinetics, Incorporated: Buyout Speculation Persists
Apr 01Cytokinetics: CEO Talks Down Buyout Prospects
Mar 16Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade)
Jan 12Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$576m |
| Jun 30 2024 | n/a | n/a | -US$545m |
| Mar 31 2024 | n/a | n/a | -US$531m |
| Dec 31 2023 | US$9m | US$790k | -US$526m |
| Sep 30 2023 | n/a | n/a | -US$527m |
| Jun 30 2023 | n/a | n/a | -US$540m |
| Mar 31 2023 | n/a | n/a | -US$431m |
| Dec 31 2022 | US$9m | US$742k | -US$389m |
| Sep 30 2022 | n/a | n/a | -US$282m |
| Jun 30 2022 | n/a | n/a | -US$216m |
| Mar 31 2022 | n/a | n/a | -US$258m |
| Dec 31 2021 | US$6m | US$709k | -US$215m |
| Sep 30 2021 | n/a | n/a | -US$229m |
| Jun 30 2021 | n/a | n/a | -US$156m |
| Mar 31 2021 | n/a | n/a | -US$135m |
| Dec 31 2020 | US$5m | US$682k | -US$127m |
| Sep 30 2020 | n/a | n/a | -US$114m |
| Jun 30 2020 | n/a | n/a | -US$140m |
| Mar 31 2020 | n/a | n/a | -US$132m |
| Dec 31 2019 | US$3m | US$656k | -US$122m |
| Sep 30 2019 | n/a | n/a | -US$118m |
| Jun 30 2019 | n/a | n/a | -US$110m |
| Mar 31 2019 | n/a | n/a | -US$105m |
| Dec 31 2018 | US$3m | US$630k | -US$106m |
| Sep 30 2018 | n/a | n/a | -US$120m |
| Jun 30 2018 | n/a | n/a | -US$131m |
| Mar 31 2018 | n/a | n/a | -US$132m |
| Dec 31 2017 | US$3m | US$612k | -US$128m |
Compensación vs. Mercado: La compensación total ($USD8.75M) de Robert está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD7.74M).
Compensación vs. Ingresos: La compensación de Robert ha aumentado mientras la empresa no es rentable.
CEO
Robert Blum (60 yo)
18.8yrs
Permanencia
US$8,751,057
Compensación
Mr. Robert I. Blum has been Chief Executive Officer, President and Director of Cytokinetics, Incorporated since January 22, 2007 and served as its Principal Financial Officer until May 08, 2024. Mr. Blum p...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 18.8yrs | US$8.75m | 0.23% $ 13.4m | |
| VP & Chief Accounting Officer | 5.5yrs | US$1.04m | 0.0063% $ 366.8k | |
| Executive Vice President of Research & Development | 12.4yrs | US$4.44m | 0.053% $ 3.1m | |
| Executive VP & Chief Commercial Officer | 3.7yrs | US$3.20m | 0.021% $ 1.2m | |
| Co-Founder & Member of Scientific Advisory Board | 27.3yrs | US$21.94k | sin datos | |
| Executive VP & CFO | less than a year | sin datos | sin datos | |
| Vice President of Sales & Operations | 3.2yrs | sin datos | sin datos | |
| Vice President of Corporate Finance and Financial Planning & Analysis | less than a year | sin datos | sin datos | |
| Senior Vice President of Global Supply Chain Operations & Technical Operations | no data | sin datos | sin datos | |
| VP & Chief Compliance Officer | 3yrs | sin datos | sin datos | |
| VP, Associate General Counsel & Corporate Secretary | no data | sin datos | sin datos | |
| Senior Vice President of Global Marketing & Commercial Strategy | 3.5yrs | sin datos | sin datos |
3.6yrs
Permanencia media
60yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CYTK se considera experimentado (3.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 17.8yrs | US$8.75m | 0.23% $ 13.4m | |
| Co-Founder & Member of Scientific Advisory Board | no data | US$21.94k | sin datos | |
| Independent Director | 11.8yrs | US$529.02k | 0.013% $ 736.5k | |
| Co-Founder & Chairman of Scientific Advisory Board | 16.6yrs | US$41.50k | sin datos | |
| Independent Director | 4yrs | US$519.02k | 0.015% $ 853.5k | |
| Independent Chairman | 15.8yrs | US$559.02k | 0.028% $ 1.6m | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | 8.3yrs | US$942.23k | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 3.8yrs | US$509.02k | 0.010% $ 590.5k |
11.8yrs
Permanencia media
68yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de CYTK son experimentados ( 11.8 años antigüedad media).